Top Markets
Coin of the day
Yubo International Biotech Limited Yubo International Biotech Limited

Yubo International Biotech Limited

YBGJ
Rank in Stocks #38245
Yubo International Biotech Limited, operating through its various subsidiaries,... Yubo International Biotech Limited, operating through its various subsidiaries, primarily dedicates its efforts to the research, development, and practical application of endometrial stem cells. Beyond this core focus, the company also provides a diverse range of products, including solutions for respiratory health, skincare and hair care formulations, nutritious beverages, and personal care items tailored for both men and women. Furthermore, it delivers specialized stem cell services, such as cellular analysis and comprehensive health management consulting, all offered under the VIVCELL brand. The company's headquarters are located in Beijing, China.
Share Price
$0.0065
Market Cap
$1.11M
Change (1 day)
-45.38%
Change (1 year)
-80.03%
Country
CN
Trade Yubo International Biotech Limited (YBGJ)

Category

P/E ratio for Yubo International Biotech Limited (YBGJ)
P/E ratio as of 2026 TTM: 0
According to Yubo International Biotech Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Yubo International Biotech Limited from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
39.92 -
US
30.38 -
FR
- -
JP
41.93 -
US
- -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.